5-Chloro-2-fluoropyridine | CAS:1480-65-5

We serve 5-Chloro-2-fluoropyridine CAS:1480-65-5 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
5-Chloro-2-fluoropyridine

Chemical Name:     5-Chloro-2-fluoropyridine
CAS.NO: 1480-65-5
Synonyms:3-Chloro-6-fluoropyridine;
5-chloro-2-fluoro-pyridine;
2-fluoro-5-chloropyridine;
2-Fluor-5-chlor-pyridin;
5-Chloro-2-Fluoropyridine;
Molecular Formula:C5H3ClFN
Molecular Weight: 131.53500
 
Physical and Chemical Properties:
Density: 1.3±0.1 g/cm3
Melting point:/
Boiling point: 158.0±20.0 °C at 760 mmHg
Flash point:49.3±21.8 °C
Index of Refraction: 1.503
 
Specification:
Appearance:Colorless to brown liquid
Purity:≥98.0%
 
Packing:25 KGS/Drum
Storage:Store in a tightly closed container. Store in a cool, dry.
Application:    used to Pharmaceutical intermediate



Contact us for information like 5-Chloro-2-fluoropyridine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,5-Chloro-2-Fluoropyridine physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-Fluor-5-chlor-pyridin Use and application,2-fluoro-5-chloropyridine technical grade,usp/ep/jp grade.


Related News: Large pharmaceutical companies are investing a disproportionately large amount of annual revenue in research and development (R&D), according to GlobalData’s Company Financials database.2-Phenylacetamide manufacturer Vietnam backtracked on Saturday and narrowed its restrictions to most flights from mainland China.4-[(5-bromo-2-chlorophenyl)methyl]phenol supplier The new restrictions on foreign nationals begin on February 3, Prime Minister Jacinda Ardern announced in a press release Sunday.2-Bromo-3,4-difluoroaniline vendor Retrogenix’s proprietary cell microarray technology provides a fast, accurate and effective solution for determining the primary target and secondary target (off-target) activities of antibodies, proteins, cell therapies, small molecules and viruses.In addition, due to the complex process of changing the API supplier and the risk of uncertainty, the viscosity of pharmaceutical and specialty API companies is usually better.